Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07054073 · ClinicalTrials.gov registry record
HCMR Re-Imaging Study
A clinical trial of Hypertrophic Cardiomyopathy (HCM), sponsored by Christopher Kramer.
- Recruiting
- Registry status
- 314
- Enrollment target
- 8
- Study locations
NCT07054073 is a study of Hypertrophic Cardiomyopathy (HCM) that is actively recruiting participants, run by Christopher Kramer. The registered enrollment target is 314 participants. The trial reports 8 study locations across 6 states.
The verdict
NCT07054073, a study of Hypertrophic Cardiomyopathy (HCM), is actively recruiting participants, sponsored by Christopher Kramer.
- RECRUITING
- Registry status
- 314 participants
- Enrollment target
- 8
- Study locations
Study Summary
This study aims to learn what might predict heart problems (like sudden death from a fast heart rhythm or heart failure) in people with a genetic condition called hypertrophic cardiomyopathy (HCM). HCM causes the heart muscle to become thick, which can make the heart stiff and harder to work properly. It can also affect the heart's electrical system. This study is looking to enroll patients that were previously part of a research project called "HCMR - Novel Predictors of Outcome in Hypertrophic Cardiomyopathy." The results of that study are still being reviewed, but they might show that people who had a substance called Gadolinium (MRI contrast or dye) collected in their heart muscle may have a higher risk for heart problems, including sudden cardiac death. This is called "late gadolinium enhancement" (LGE). This study is aiming to do follow-up imaging on those patients to better understand how LGE affects people with HCM.
Conditions Studied
Interventions
- OTHER None - observational study
Study Locations (8)
Massachusetts
- Brigham & Women's Hospital - Boston
- Tufts Medical Center - Medford
Other
- University Hospitals Birmingham NHS Foundation Trust - Birmingham
- London Chest Hospital - London
Illinois
- Northwestern - Evanston
Michigan
- University of Michigan - Ann Arbor
Ohio
- Cleveland Clinic - Cleveland
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 314 participants |
| Start Date | 2026-03-30 |
| Est. Completion | 2027-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07054073
The ClinicalTrials.gov registry entry for NCT07054073 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 314 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Christopher Kramer, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypertrophic Cardiomyopathy (HCM) appearing as the primary indexed condition, and to 1 intervention - of which None - observational study is the first listed.
NCT07054073 reports 8 study locations spanning 6 distinct geographic areas - top geographies include Massachusetts, Other, Illinois.
Frequently Asked Questions
What is clinical trial NCT07054073 about?
NCT07054073 is a clinical study titled "HCMR Re-Imaging Study". This study aims to learn what might predict heart problems (like sudden death from a fast heart rhythm or heart failure) in people with a genetic condition called hypertrophic cardiomyopathy (HCM). HCM causes the heart muscle to become thick, which can make the heart stiff and harder to work properl...
What is the current status of trial NCT07054073?
This trial is currently recruiting. The enrollment target is 314 participants. The study started on 2026-03-30. Estimated completion is 2027-07.
What conditions does trial NCT07054073 study?
This clinical trial studies the following conditions: Hypertrophic Cardiomyopathy (HCM).
What interventions are being tested in trial NCT07054073?
The interventions under investigation include: None - observational study (OTHER).
Who is sponsoring clinical trial NCT07054073?
This trial is sponsored by Christopher Kramer, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07054073 being conducted?
This trial has 8 study locations across Illinois, Massachusetts, Michigan, Ohio, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertrophic Cardiomyopathy (HCM)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.